Intralesional SD-101 in Combination With Pembrolizumab in Anti–PD-1 Treatment-Naive HNSCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intralesional SD-101 in combination with pembrolizumab in anti-PD-1 treatment naive head and neck squamous cell carcinoma: results from a multicenter, phase 2 trial
Clin. Cancer Res 2021 Dec 29;[EPub Ahead of Print], EEW Cohen, L Nabell, DJ Wong, T Day, GA Daniels, M Milhem, S Deva, M Jameson, O Guntinas-Lichius, M Almubarak, M Strother, E Whitman, M Chisamore, C Obiozor, T Bagulho, J Gomez-Romo, C Guiducci, R Janssen, E Gamelin, AP AlgaziFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.